List of Tables
Table 1. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Biologics
Table 3. Key Players of Small Molecule Targeted Therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Other
Table 6. Global Non-small Cell Lung Cancer Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Non-small Cell Lung Cancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Non-small Cell Lung Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Non-small Cell Lung Cancer Drugs Market Share by Region (2019-2024)
Table 10. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Non-small Cell Lung Cancer Drugs Market Share by Region (2025-2030)
Table 12. Non-small Cell Lung Cancer Drugs Market Trends
Table 13. Non-small Cell Lung Cancer Drugs Market Drivers
Table 14. Non-small Cell Lung Cancer Drugs Market Challenges
Table 15. Non-small Cell Lung Cancer Drugs Market Restraints
Table 16. Global Non-small Cell Lung Cancer Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Non-small Cell Lung Cancer Drugs Market Share by Players (2019-2024)
Table 18. Global Top Non-small Cell Lung Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2023)
Table 19. Ranking of Global Top Non-small Cell Lung Cancer Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Non-small Cell Lung Cancer Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-small Cell Lung Cancer Drugs Product Solution and Service
Table 23. Date of Enter into Non-small Cell Lung Cancer Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-small Cell Lung Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. AstraZeneca Company Detail
Table 49. AstraZeneca Business Overview
Table 50. AstraZeneca Non-small Cell Lung Cancer Drugs Product
Table 51. AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)
Table 52. AstraZeneca Recent Development
Table 53. Bristol-Myers Squibb Company Company Detail
Table 54. Bristol-Myers Squibb Company Business Overview
Table 55. Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Product
Table 56. Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)
Table 57. Bristol-Myers Squibb Company Recent Development
Table 58. Eli Lilly and Company Company Detail
Table 59. Eli Lilly and Company Business Overview
Table 60. Eli Lilly and Company Non-small Cell Lung Cancer Drugs Product
Table 61. Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)
Table 62. Eli Lilly and Company Recent Development
Table 63. F. Hoffmann-La Roche Ltd Company Detail
Table 64. F. Hoffmann-La Roche Ltd Business Overview
Table 65. F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Product
Table 66. F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)
Table 67. F. Hoffmann-La Roche Ltd Recent Development
Table 68. Merck & Co., Inc. Company Detail
Table 69. Merck & Co., Inc. Business Overview
Table 70. Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Product
Table 71. Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2019-2024) & (US$ Million)
Table 72. Merck & Co., Inc. Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-small Cell Lung Cancer Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Non-small Cell Lung Cancer Drugs Market Share by Type: 2023 VS 2030
Figure 3. Biologics Features
Figure 4. Small Molecule Targeted Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Other Features
Figure 7. Global Non-small Cell Lung Cancer Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Non-small Cell Lung Cancer Drugs Market Share by Application: 2023 VS 2030
Figure 9. Lung Adenocarcinoma Case Studies
Figure 10. Squamous Cell Lung Carcinoma Case Studies
Figure 11. Large-cell Lung Carcinoma Case Studies
Figure 12. Non-small Cell Lung Cancer Drugs Report Years Considered
Figure 13. Global Non-small Cell Lung Cancer Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Non-small Cell Lung Cancer Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Non-small Cell Lung Cancer Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Non-small Cell Lung Cancer Drugs Market Share by Players in 2023
Figure 17. Global Top Non-small Cell Lung Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Non-small Cell Lung Cancer Drugs Revenue in 2023
Figure 19. North America Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Non-small Cell Lung Cancer Drugs Market Share by Country (2019-2030)
Figure 21. United States Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Non-small Cell Lung Cancer Drugs Market Share by Country (2019-2030)
Figure 25. Germany Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Share by Region (2019-2030)
Figure 33. China Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Non-small Cell Lung Cancer Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)
Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)
Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)
Figure 51. Merck & Co., Inc. Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed